Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1 – SNAI1 axis
The Journal of Pathology · 2024
DOI: 10.1002/path.6325 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2024. Verfasst von Ze Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Daping Hospital, Army Medical University, Chongqing, PR China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Snail Family Transcription Factors, Epithelial-Mesenchymal Transition, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, University Research Project of Army Medical University.
Abstract (Originalsprache)
Metastasis is the primary culprit behind cancer‐related fatalities in multiple cancer types, including prostate cancer. Despite great advances, the precise mechanisms underlying prostate cancer metastasis are far from complete. By using a transgenic mouse prostate cancer model (TRAMP) with and without Phf8 knockout, we have identified a crucial role of PHF8 in prostate cancer metastasis. By complexing with E2F1, PHF8 transcriptionally upregulates SNAI1 in a demethylation‐dependent manner. The upregulated SNAI1 subsequently enhances epithelial‐to‐mesenchymal transition (EMT) and metastasis. Given the role of the abnormally activated PHF8/E2F1‐SNAI1 axis in prostate cancer metastasis and poor prognosis, the levels of PHF8 or the activity of this axis could serve as biomarkers for prostate cancer metastasis. Moreover, targeting this axis could become a potential therapeutic strategy for prostate cancer treatment. © 2024 The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Daping Hospital, Army Medical University, Chongqing, PR China.
- Chongqing Key Laboratory of High Active Traditional Chinese Drug Delivery System, Chongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing, PR China.
- College of Pharmacy, Chongqing Medical University, Chongqing, PR China.
- Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA.
- CAS Key Laboratory of Tissue Microenvironment and Tumor, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health Sciences, Chinese Academy of Sciences, University of Chinese Acade…
Förderung
- National Natural Science Foundation of China
- University Research Project of Army Medical University
Zitieren
APA
Wang, Z., Tang, P., Xiao, H., Peng, S., Chen, J., Wang, Y., Xu, J., Yan, Q., Zhang, J., Deng, J., Ma, Q., Zhu, H., Luo, W., Zhang, D., Wang, L., Qin, J., Lan, W., Jiang, J., & Liu, Q. (2024). Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1 – SNAI1 axis. The Journal of Pathology. https://doi.org/10.1002/path.6325
Vancouver
Wang Z, Tang P, Xiao H, Peng S, Chen J, Wang Y, et al. Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1 – SNAI1 axis. The Journal of Pathology. 2024. doi:10.1002/path.6325
BibTeX
@article{Wang2024,
author = {Wang, Ze and Tang, Peng and Xiao, Haiyang and Peng, Song and Chen, Jian and Wang, Yapeng and Xu, Jing and Yan, Qian and Zhang, Junying and Deng, Jie and Ma, Qiang and Zhu, Hailin and Luo, Weiming and Zhang, Dianzheng and Wang, Luofu and Qin, Jun and Lan, Weihua and Jiang, Jun and Liu, Qiuli},
title = {Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1 – SNAI1 axis},
journal = {The Journal of Pathology},
year = {2024},
doi = {10.1002/path.6325}
}
EUVIMED